NERV (STOCKS)
Minerva Neurosciences, Inc
$5.700000
+0.190000 (+3.45%)
Prev close: $5.510000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Rémy Henri Luthringer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $245.80M
- Employees
- 8
- P/E (TTM)
- -0.21
- P/B (TTM)
- -1.75
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.64 | $-0.31 | -0.3340 | -109.15% |
|
Jun 2025 (Q2)
|
$-0.43 | $-0.92 | +0.4880 | +53.16% |
|
Mar 2025 (Q1)
|
$-0.50 | $-1.09 | +0.5914 | +54.19% |
|
Dec 2024 (Q4)
|
$-0.56 | $-1.07 | +0.5110 | +47.71% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $15.10M |
| Depreciation and Amortization | $5.44K |
| Research and Development | $5.76M |
| Other Operating Expenses | $9.34M |
| Operating Income/Loss | -$15.10M |
| Income/Loss From Continuing Operations After Tax | -$293.42M |
| Income/Loss From Continuing Operations Before Tax | -$293.42M |
| Net Income/Loss | -$293.42M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$293.42M |
| Net Income/Loss Available To Common Stockholders, Basic | -$293.42M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$34.67 |
| Diluted Earnings Per Share | -$34.67 |
| Basic Average Shares | 8,463,581 |
| Diluted Average Shares | 8,463,581 |
| Assets | $97.97M |
| Current Assets | $83.10M |
| Prepaid Expenses | $697.68K |
| Other Current Assets | $82.40M |
| Noncurrent Assets | $14.87M |
| Fixed Assets | $0.00 |
| Liabilities | $233.76M |
| Current Liabilities | $2.29M |
| Accounts Payable | $639.71K |
| Other Current Liabilities | $1.65M |
| Noncurrent Liabilities | $231.46M |
| Equity | -$140.75M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$140.75M |
| Liabilities And Equity | $97.97M |
| Net Cash Flow From Operating Activities | -$13.51M |
| Net Cash Flow From Operating Activities, Continuing | -$13.51M |
| Net Cash Flow From Investing Activities | -$60.94M |
| Net Cash Flow From Investing Activities, Continuing | -$60.94M |
| Net Cash Flow From Financing Activities | $74.45M |
| Net Cash Flow From Financing Activities, Continuing | $74.45M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$293.42M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$293.42M |
| Other Comprehensive Income/Loss | $0.00 |